Digital breast tomosynthesis is comparatively a new technology that improves the radiologists ability to treat breast cancer. It is also known as 3D mammography as it uses a series of two-dimensional images to create a three-dimensional image of the breast using x-rays. Breast tomosynthesis aids in early detection and diagnosis of breast disease.
Increase in prevalence of breast cancer across the globe and increase in the adoption of Digital Breast Tomosynthesis Devices by various healthcare professionals as a primary source of detection of breast cancer and specifically, in the dense breast are driving the Digital Breast Tomosynthesis Market during the forecast period.
Major factors hindering the Digital Breast Tomosynthesis Market during the forecast period are a high cost associated with the device and availability of alternatives.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
